The closing bell on U.S. stock markets may have rung a mostly somber note last Friday, but astute investors had reason to cheer with a series of insider trades lighting up the financial landscape.
Insiders betting big indicates not just faith in the company’s future but also a belief the stock is undervalued. It’s akin to spotting a rare gem in a sea of gravel – a chance to ride a bullish wave. While insider moves aren’t the single metric for investment decisions, they serve as a sturdy vote of confidence.
Let’s delve into some recent noteworthy insider trades that are stirring up the market waters. For more, venture into Benzinga’s insider transactions platform.
Insider Insight: Harrow
- The Lowdown: Harrow, Inc. HROW saw Opaleye Management Inc., a 10% owner, snagging 50,600 shares at an average price of $9.65. The total price tag for this stake? A cool $488,290.
- Under the Microscope: March 19 witnessed Harrow unveiling fourth-quarter financials that failed to hit the mark.
- What’s Harrow About: Harrow Inc plays in the eyecare pharmaceutical domain, dabbling in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market.
Greenwich LifeSciences Gains Momentum
- The Skinny: Greenwich LifeSciences, Inc. GLSI witnessed CEO and CFO Snehal Patel jumping on board, acquiring 1,500 shares at $17.68 on average. This move set back Patel around $26,520.
- The Buzz: March 12 marked Greenwich LifeSciences kicking off clinical trials in Europe, partnering with GEICAM in Spain.
- What’s in the Pipeline: Greenwich LifeSciences Inc is knee-deep in clinical-stage biopharmaceutical pursuits, centering on GP2 – an immunotherapy aimed at stymying breast cancer recurrences in surgery veterans.
Beep beep! Don’t miss out on our latest premarket insights here
Real Estate Rumble with BRT Apartments
- The Revelation: BRT Apartments Corp. BRT saw Gould Investors L P, a 10% stakeholder, snapping up 3,471 shares at an average cost of $16.26. The price tag for this action? A hefty $56,450.
- The Lowdown: March 12 painted a gloomy picture for BRT Apartments with less-than-upbeat quarterly sales figures.
- What’s BRT About: BRT Apartments Corp stands tall as a real estate investment trust player, honing its focus on the ownership, operation, and development of multifamily properties.
Catch this: Dive into the top 5 consumer stocks that might take a nosedive this month
Simplifying the market for savvy investing
Trade smarter with insights, alerts on analyst ratings, free reports, and breaking news that impacts your stock interests.